Androgenic alopecia (AGA), or male pattern hair loss, is the most common form of hair loss and affects up to 50% of all men by the age of 50. This article looks at the pathophysiology, diagnosis and treatment (both medical and surgical) of AGA.
Get full access to this article
View all access options for this article.
References
1.
SperlingL.C., MezebishD.S.Hair disease. Med Clin North Am, 1998; 82:1155–1169.
PriceV.H.Treatment of hair loss. N Engl J Med, 1999; 341(13):964–973.
4.
SawayaM.E.Purification of androgen receptors in human sebocytes and hair. J Invest Dermatol, 1992; 98:92S–96S.
5.
VierhapperH., NowotnyP., MaierH., WaldhäuslW.Production rates of dihydrotestosterone in healthy men and women and in men with male pattern baldness: determination by stable isotope/dilution and mass spectrometry. J Clin Endrocrinol Metab, 2001; 86:5762–5764.
6.
SawayaM.E., PriceV.H.Different levels of 5-alpha-reductase type I and II, aromatase, and androgen receptors in hair follicles of women and men with androgenic alopecia. J Invest Dermatol, 1997; 109:296–300.
7.
Imperato-McGinleyJ., GuerreroL., GautierT., PetersonR.E.Steroid 5α-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science, 1974; 186:1213–1215.
8.
HamiltonJ.B.Male hormone stimulation is prerequisite and an incitant in common baldness. Am J Anat, 1942; 71:451–480.
9.
KüsterW., HappleR.The inheritance of common baldness: two B or not two B?.J Am Acad Dermatol, 1984; 11(5 Pt 1):921–926.
10.
HillmerA.M., HannekenS., RitzmannS., BeckerT., FreudenbergJ., BrockschmidtF.F., et al.Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet, 2005; 77:140–148.
11.
SpringerK., BrownM., StulbergD.L.Common hair loss disorders. Am Fam Physician, 2003; 68:93–102: Comment: 107–8.
12.
MounseyA.E., ReedS.W.Diagnosing and treating hair loss. Am Fam Physician, 2009; 80(4):356–362: Comment: 373–4.
13.
RushtonD.H., RamsayI.D., NorrisM.J., GilkesJ.J.Natural progression of male pattern baldness in young men. Clin Exp Dermatol, 1991; 16(3):188–192.
14.
OlsenE.A., WeinerM.S., DelongE.R., PinnellS.R.Topical minoxidil in early male pattern baldness. J Am Acad Dermatol, 1985; 13:185–192.
15.
OlsenE.A., DunlapF.E., FunicellaT., KoperskiT., SwinehartJ.M., TschenE.H., et al.A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol, 2002; 47:377–385.
16.
PriceV.H., MenefeeE., StraussP.C.Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment. J Am Acad Dermatol, 1999; 41:717–721.
17.
PriceV.H., MenefeeE., SanchezM., RuaneP., KaufmanK.D.Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily. J Am Acad Dermatol, 2002; 46:517–523.
18.
PriceV.H., MenefeeE., SanchezM., KaufmanK.D.Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results. J Am Acad Dermatol, 2006; 55:71–74.
19.
KaufmanK.D., RotondaJ., ShahA.K., MeehanA.G.Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss). Eur J Dermatol, 2008; 18(4):400–406.
20.
StoughD.B., RaoN.A., KaufmanK.D., MitchellC.Finasteride improves male pattern hair loss in a randomized study in identical twins. Eur J Dermatol, 2002; 12(1):32–37.
21.
AmoryJ.K., AnawaltB.D., MatsumotoA.M., PageS.T., BremnerW.J., WangC., et al.The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men. J Urol, 2008; 179:2333–2338.
22.
AmoryJ.K., WangC., SwerdloffR.S., AnawaltB.D., MatsumotoA.M., BremnerW.J., et al.The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men. J Clin Endocrinol Metab, 2007; 92:1659–1665.
23.
OlsenE.A., HordinskyM., WhitingD., SloughD., HobbsS., EllisM.L., et al.The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol, 2006; 55:1014–1023.
24.
OverstreetJ.W., FuhV.L., GouldJ., HoardsS.S., LieberM.M., HellstromW., et al.Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol, 1999; 162:1295–1300.
OhB.R., KimS.J., MoonJ.D., KimH.N., KwonD.D., WonY.H., et al.Association of benign prostatic hyperplasia with male pattern baldness. Urology, 1998; 51:744–748.
27.
HawkE., BreslowR.A., GraubardB.I.Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev, 2000; 9:523–527.
28.
LotufoP.A., ChaeC.U., AjaniU.A., HennekensC.H., MansonJ.E.Male pattern baldness and coronary heart disease: the Physicians’ Health Study. Arch Intern Med, 2000; 160:165–171.
29.
MatilainenV., KoskelaP., Keinanen-KiukaanniemiS.Early androgenetic alopecia as a marker of insulin resistance. Lancet, 2000; 356:1165–1166.
30.
DuskovaM., HillM., StarkaL.Changes of metabolic profile in men treated for androgenetic alopecia with 1 mg finasteride. Endocr Regul, 2010; 44(1):3–8.
31.
SasakiS., HozumiY., KondoS.Influence of prostaglandin F2alpha and its analogues on hair regrowth and follicular melanogenesis in a murine model. Exp Dermatol, 2005; 14:323–328.
32.
UnoH., ZimbricM.L., AlbertD.M., StjernschantzJ.Effect of latanoprost on hair growth in the bald scalp of the stump-tailed macacque: a pilot study. Acta Derm Venereol, 2002; 82(1):7–12.
33.
LeeS.T., MintonJ.T.An update on hair restoration therapy. Curr Opin Otolaryngol Head Neck Surg, 2009; 17:287–294.
WellsP.A., WillmothT., RussellR.J.Does fortune favour the bald? Psychological correlates of hair loss in males. Br J Psychol, 1995; 86(pt 3):337–344.
36.
CashT.F.Losing hair, losing points? The effects of male pattern baldness on social impression formation. J Appl Soc Psychol, 1990; 20(2, pt 1):154–167.
37.
LlauM.E., VirabenR., MontastrucJ.L.Drug-induced alopecia: review of the literature. Therapie, 1995; 50(2):145–150.
38.
NaslundM., EaddyM.T., KruepE.J., HogueS.L.Cost comparison of finasteride and dutasteride for enlarged prostate in a managed care setting among Medicare-aged men. Am J Manag Care, 2008; 14(5 Suppl 2):S167–S171.
39.
AbramowiczM.Finasteride and minoxidil for alopecia revisited. Medical Letter Drugs Therapeutics, 2005; 47( issue 1222):95.
